8th Antigen-Specific Immune Tolerance Summit

Immune tolerance offers a transformative approach to autoimmune diseases treatment and holds the power to modify the course of disease progression and significantly improve the quality of life for patients.

For 7 years, the 8th Antigen-Specific Immune Tolerance Summit has been at the forefront of innovative and novel approaches to immunology and inflammation and facilitated the development of new industry connections, research partnerships and seed investment across the immune tolerance field.

In 2025, this highly anticipated meeting will delve further into the complex reality of inducing immune tolerance as the landscape evolves with Diamyd, Annokion, COUR and more being the custodians of rapidly progressing clinical tirals.

From antigen selection, to establishing biomarkers of tolerance to brand-new clinical readouts, join 120+ autoimmune, immunology and inflammation experts at this timely and comprehensive network to continue to drive the momentum in the field.